UK biotech helping pharma target intrinsically disordered proteins for drug discovery.
| Date | Round | Amount |
|---|---|---|
| Jun 2022 | Series A London protein-modelling biotech Peptone raised a 40M dollar Series A led by F-Prime Capital and Bessemer Venture Partners, with Walden Catalyst and Novartis' dRX Capital. | $38.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.